| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |